Sunday, August 2, 2026

North Korea-Russia Alliance: What’s Next After 2 Years of Strategic Partnership?

North Korea emphasizes strengthening ties with Russia on the treaty's anniversary, highlighting political, economic, and cultural cooperation.

US North Korea Sanction Easing, Still Attractive Card… South Korea Must Focus On “Mediator”

Experts suggest easing U.S. sanctions on North Korea could improve inter-Korean relations and facilitate denuclearization talks.

Tesla Shares Dip 1% Amid Growing Tariff Fears and European Struggles

Tesla's stock fell 1% amid concerns over tariffs and Ford's revenue forecast cut, despite a 45% rise since Trump's election.

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.
Latest

Korean MSD Partners with 13 Biotech Firms to Act as Global Collaboration Hub

Korean MSD held an Open Innovation Week to enhance collaboration with local biotech firms, aiming for technology exchanges and joint research.

Matica BIOLABS Signs CMO with Jeongjin Bioscience for Mesenchymal Stem Cell Culture Media Production

Matica BIOLABS partners with Jeongjin Bioscience for stem cell media production and expands operations with Humic for drug development.

GC Cell Secures Japanese Certification for the Manufacture of Specific Cell Processing Products

GC Cell receives final certification from Japan for cell processing products, validating its manufacturing and quality systems for regenerative medicine.

AITRICS Showcases Clinical Value and Real-World Applications of AITRICS-VC (VitalCare) Solution

AITRICS showcased its VitalCare AI solution for predicting critical health conditions at a symposium, enhancing clinical decision-making.

Daewoong Pharmaceutical Completes Global Phase 2 Trials for First-in-Class IPF Treatment

Daewoong Pharmaceutical completes patient recruitment for a Phase 2 trial of Bersiporocin, a potential treatment for idiopathic pulmonary fibrosis.

Tailored Chemotherapy Boosts Survival Rates for Elderly Colon Cancer Patients

A study reveals tailored treatment for elderly colon cancer patients boosts survival rates, challenging age-based treatment limitations.

HLB Group Appoints Yang Eun-young President of Bio Business Development Division

HLB Group appoints Yang Eun-young as President of Bio Business Development, focusing on global partnerships and commercialization strategies.

VAIM Hosts JUVELOOK and juveàcell Symposium in Busan for Aesthetic Medicine and Treatment

VAIM hosted the JUVELOOK & juveàcell Symposium in Busan, showcasing advancements in aesthetic medicine for healthcare providers.

Curocell’s RIMQARTO®: The First CAR-T Therapy in Korea, with Plans for Global Release

Curocell aims to lead in CAR-T therapies with RIMQARTO's approval, focusing on solid tumors and global expansion strategies.

Qurient Mocaciclib’s CDK7 Inhibitor is Revolutionizing High-Risk Pediatric Brain Cancer Therapy

Qurient's Mocaciclib shows promising results for pediatric brain tumors, enhancing survival and overcoming treatment barriers.

AITRICS: “Medical Artificial Intelligence (AI) is No Longer a Choice”

Medical AI must prove its real-world value. AITRICS focuses on tools that enhance decision-making and integrate into healthcare workflows.

i-SENS CareSens Air 2: The Future of Blood Sugar Monitoring in 2026

i-SENS is expanding globally with the CareSens Air 2, enhancing digital features for better diabetes management and market competitiveness.

South Korea Initiates Preparations for AI Basic Medical Care to Ensure Universal Access to High-quality Medical Services

The South Korean government is launching AI Basic Healthcare to improve medical access and address regional disparities in healthcare.

PharmGen Science Releases Tabapheno Extended-Release for Dyslipidemia Treatment

PharmGen Science launches Tabapheno Extended-Release Tablets for mixed dyslipidemia, enhancing treatment convenience and adherence.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.